Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
"Avacta don't need live variants to design new tests. The need purified S protein from the variants, which they can do going via synthetic dna route."
Tell that to the vaccine makers as well, why do you think they are testing it against real live virus, maybe for real world testing?
17th March:
"Investors so overlook Alistair's genius. Judging from this mornings interview he's found a way to circumvent Porton Down clinical evaluation stage so Avacta will be able to bid for Government tender with a CE Mark on 7th April. Just shows how eager governments must be to buy UK LFT that their wiling to bend their requirements for us :-)"
Have you heard of Zika for a while in the news?
"Why hide history, why hide Zika"
- Where is it hidden? Please explain
VentureCatipila wrote this on
25th Feb:
"Love how adaptable affimers can be. Alistar said they can even update LFT in future if the current one can't detect future mutations to the Spike protein."
3rd March:
"We got a great in house PR team, no one's better than Alistair."
6th March:
"AS has played another blinder, CE Mark by end of March, then get clinical approval done in time to submit LFT bid by 7th April. Doff my cap to you Sir Al"
17th March:
"Investors so overlook Alistair's genius. Judging from this mornings interview he's found a way to circumvent Porton Down clinical evaluation stage so Avacta will be able to bid for Government tender with a CE Mark on 7th April. Just shows how eager governments must be to buy UK LFT that their wiling to bend their requirements for us :-)"
Then this today:
"Will Affimers and Aptamers be the same. We just have AS's word. But he's not a man of his word"
You sir need some medication for your Bipolar, which is it, is AS a liar or a genius?
You are all over the place!
Mumbo your not an expert, lets leave it to the experts hey
VentureCatipilla, of course there is always a risk with anything you put in the body, risk has to be assessed and both you and me are in no way capable of assessing that risk. I have no background in Biomolecular Physics or Biotechnology in general, but I am fascinated by it. So one of the best ways I can judge these risks is with the partners who choose to collaborate with Avacta, and want to spend millions on using Affimers in the body or for other purposes
Moderna want to do it
Daewoong want to do it
After doing due diligence these companies keep coming back and expanding these partnerships with Avacta. I see this as MAJOR validation, it doesn't mean everything is without risk but its a sign. The one really perfect way to alleviate any doubt or risk is to do the trials which they will be doing, if those trials go well Avacta's share will go up much much more. But still people will come on to this board and continue to say the same things.
I prefer to listen to those with expertise in these areas like Avacta, Moderna, LG Chemicals, Daewoong, Point Biopharma, Astrea Bioseperations, ADC Therapeutics, Biokit, Selexis, Mologic, Bruker, Adeptrix, Cytiva, New England Biolabs, Fit Biotech, Oncosec, Glythera, Covance etc... rather than anonymous posters on a board
And who invests like Conifer Management LLC (American Hedgefund) and the likes of Samsung
Mumbo you wrote:
"If South African variant like mutants become dominant, then any test has to be to detect it, otherwise it would be a waste of time." - IF (BIG IF) the South African mutant becomes dominant, so you seem to be suggesting that we take the risk and design the test to pick up the S.A mutation just in case it becomes dominant while ignore the current dominant Kent mutation that is currently taking over the world. Not sure I agree with your risky strategy there?
I think i'm more happy to trust Alistair Smith's judgement to be honest, he's done well in the last year and half
Venture you seem confused, and changing tack rather than understanding whats going on. You are trying to raise issues that don't exist.
Mumbo your point is applicable to every Covid test and Vaccine that targets the spike protein - all testing companies have this as an issue to face. Now that the test architecture has been completed and tweaked/refined the hard work is done. If it is needed as Alistair has said it is now easy and quick to drop new Affimers in the strip.
Just wondering whether Avacta could make several Affimers which target the different variants and then put all the different affimers into the strip and then will pick any of several variants. Would be interesting to know if this would work?
VentureCatipilla - It's actually about 4 weeks to produce a new Affimer to target a new Variant, the year you mention was to get the test right and find the right test strip then refine it - it takes time. As Alistair has said, the exciting thing now is that we have the test created, the time to make a test now for any disease is 4 weeks! Create the Affimer and drop it into the test, the hard work has been done, we can expect many other tests going forward from Avacta which is very exciting as this is a growing market
"However, some measures, such as test, trace, and isolate, good hand hygiene, mask-wearing in high-risk settings, and tracing from super-spreader events, may also be necessary for some time," Prof Keeling explained."
https://news.sky.com/story/vaccinations-alone-are-unlikely-to-contain-coronavirus-infections-in-the-uk-study-warns-12250239
A long and very detailed article on rapid testing from 3 Feb in British Medical Journal, apologies if already posted
"Conclusion
Rapid tests provide new opportunities to find and isolate cases and contacts early in the infection. However, implementing such tests in local health systems is complex. Continued formative evaluation is needed if such testing is to simultaneously reduce transmission and alleviate the mounting harms from control measures. Pilots of the SMART approach provide evidence of large scale, targeted use of lateral flow tests. Successful approaches to control covid-19 must facilitate earlier and better targeted isolation of the most infectious people and their close contacts while, where the evidence supports, releasing non-infectious contacts sooner from unnecessary quarantine and returning to a more open society and economy. This requires testing to be integrated into a comprehensive programme, co-created with local leaders and communities, including effective contact tracing, appropriate support and credible incentives for those isolating, and strategic testing as part of ongoing surveillance of vaccine effectiveness. A holistic public health approach, joined up across towns, cities, and regions, is key to sustainable recovery from the covid-19 pandemic."
https://www.bmj.com/content/372/bmj.n208
"The Avacta board seem to have it in for us....either getting a little scared or they haven’t had a snickers in a LONG while hahaha"
Absolutely incorrect, tonight's response from Avacta holders was specifically down to Tsales rather pathetic attempt at scaring Avacta holders over the publishing of the GAD Tender. Which backfired on him.
As I have stated many times I wish ALL holders of ODX and AVACTA all the best. But false information will be called out and corrected, that's all.
I'm sure I speak for all holders of both companies, that we are all dying to know the details and specifics and this long wait is excruciating!!
Once again, GOOD LUCK to all of you
Or just sell shares like ODX directors?
No all this was aimed at Tsales, for his pathetic unresearched attempt to instill fear on the Avacta board, people are well researched on Avacta BB unlike Tsales
Well Tsales if your CEO was as proactive as Avacta's you might not be languishing below £1
Well Tsales since you posted on Avacta board we went up, thanks :)
Some info from the horses mouth as it were
https://vimeo.com/509696960
Thanks Tsales :)